Transcutaneous Diaphragm Electrical Stimulation in Critically Ill Patients

NCT ID: NCT04171024

Last Updated: 2022-08-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-12-10

Study Completion Date

2022-08-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the effect of a transcutaneous electrical stimulation in critically ill patients compared to a sham electrical stimulation to decrease the incidence of diaphragm dysfunction before mechanical ventilation weaning.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness Mechanical Ventilation Intensive Care Unit

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sham Group

Two channels with two electrodes each were placed above and below the right and left sides of the xiphoid process within the seventh and eighth anterior intercostal space. In addition, two channels with two electrodes each were placed on the right and left midaxillary line of the seventh and eighth anterior intercostal space.

Transcutaneous electrical stimulation settings: Frequency (2 hertz); wave length (300 µs);

Group Type SHAM_COMPARATOR

Sham electrical stimulation

Intervention Type DEVICE

A non invasive sham diaphragm electrical stimulation using transcutaneous thoracic probes

Transcutaneous diaphragm electrical stimulation group

Two channels with two electrodes each were placed above and below the right and left sides of the xiphoid process within the seventh and eighth anterior intercostal space. In addition, two channels with two electrodes each were placed on the right and left midaxillary line of the seventh and eighth anterior intercostal space.

Transcutaneous electrical stimulation settings: Frequency (35 hertz); wave length (300 µs); Intensity to achieve a visual contraction

Group Type EXPERIMENTAL

Transcutaneous diaphragm electrical stimulation

Intervention Type DEVICE

A non invasive diaphragm electrical stimulation using transcutaneous thoracic probes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sham electrical stimulation

A non invasive sham diaphragm electrical stimulation using transcutaneous thoracic probes

Intervention Type DEVICE

Transcutaneous diaphragm electrical stimulation

A non invasive diaphragm electrical stimulation using transcutaneous thoracic probes

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients intubated and ventilated for at least 24 h
* Patients who were expected to have at least 48h after inclusion

Exclusion Criteria

* Patient with pacemaker
* Patient under neuro muscular blocker
* Patient post thoracic or abdominal surgery
* Patient with BMI more than 35 kg/m²
* Patient with degenerative neurological pathology
* Patient with cutaneous lesion may be interfered with probes
* Patient with chronic loss of autonomy
* Patient hospitalized more than 72 hours before ICU admission
* Patient with severe chronic obstructive pulmonary disease (FEV1 \< 30%)
* Patient with decision to withhold life-sustaining treatment
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Groupe Hospitalier du Havre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Clément MEDRINAL

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medrinal

Le Havre, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Medrinal C, Machefert M, Lamia B, Bonnevie T, Gravier FE, Hilfiker R, Prieur G, Combret Y. Transcutaneous electrical diaphragmatic stimulation in mechanically ventilated patients: a randomised study. Crit Care. 2023 Aug 30;27(1):338. doi: 10.1186/s13054-023-04597-1.

Reference Type DERIVED
PMID: 37649092 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-A00782-55

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.